Remote patient monitoring: Will COVID-19 bring about lasting change?

Posted by Lukas Grabner on April 21, 2020

Vijesh Unnikrishnan co-wrote this post with Lukas Grabner
 
The impact of COVID-19 has been sub stantial to all industries and our daily lives. While the negative effects are apparent, it’s also evident that this pandemic has led to 

>
Read More

Gut Feeling, Instinct, Anecdotal Evidence: Why Can’t We Just Use Data for Commercial Decisions?

Posted by Lukas Grabner on April 11, 2019

I’m often surprised by the amount of commercial strategy decisions that medtech leaders need to make despite a lack of analytic proof points. Many times, important conclusions are reached by an overemphasis on instinct, anecdotal evidence and individual in-market experiences but limited quantifiable backing. 


>
Read More

Home vs. Away: Lessons on Customizing Your Go-to-Market Game Plan

Posted by Lukas Grabner on March 9, 2018

During my time with ZS, I’ve had the opportunity to live and work both in Europe and the U.S. Once I returned to Europe last year after spending two years in our San Francisco office, I reflected a bit on the differences between the two markets and the typical challenges that our clients encounter when entering them.


>
Read More